Education
About Us
Working with TipRanks
Follow Us
Insmed (INSM)
NASDAQ:INSM
Total Valuation
Insmed has a market cap or net worth of $41.21B. The enterprise value is $29.56B.
Market Cap$41.21B
Enterprise Value$29.56B
Share Statistics
Insmed has 213,273,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding213,273,470
Owned by Insiders0.91%
Owned by Institutions11.90%
Financial Efficiency
Insmed’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -50.32%.
Return on Equity (ROE)-3.20
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-50.32%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee286.16K
Profits Per Employee-718.94K
Employee Count1,271
Asset Turnover0.18
Inventory Turnover0.87
Valuation Ratios
The current PE Ratio of Insmed is ―. Insmed’s PEG ratio is -2.88.
PE Ratio―
PS Ratio31.14
PB Ratio39.69
Price to Fair Value39.69
Price to FCF-16.05
Price to Operating Cash Flow-46.25
PEG Ratio-2.88
Income Statement
In the last 12 months, Insmed had revenue of 363.71M and earned -913.77M in profits. Earnings per share was -5.57.
Revenue363.71M
Gross Profit277.96M
Operating Income-878.25M
Pretax Income-910.07M
Net Income-913.77M
EBITDA-818.79M
Earnings Per Share (EPS)-5.57
Cash Flow
In the last 12 months, operating cash flow was -883.40M and capital expenditures -22.74M, giving a free cash flow of -906.14M billion.
Operating Cash Flow-883.40M
Free Cash Flow-906.14M
Free Cash Flow per Share-4.25
Dividends & Yields
Insmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change173.49%
50-Day Moving Average164.45
200-Day Moving Average108.55
Relative Strength Index (RSI)74.46
Average Volume (3m)2.07M
Important Dates
Insmed upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 5.45, with Debt / Equity ratio of 78.80%
Current Ratio5.45
Quick Ratio5.12
Debt to Market Cap0.11
Net Debt to EBITDA-0.92
Interest Coverage Ratio-10.34
Taxes
In the past 12 months, Insmed has paid 3.71M in taxes.
Income Tax3.71M
Effective Tax Rate>-0.01
Enterprise Valuation
Insmed EV to EBITDA ratio is -14.75, with an EV/FCF ratio of -17.12.
EV to Sales33.21
EV to EBITDA-14.75
EV to Free Cash Flow-17.12
EV to Operating Cash Flow-17.66
Balance Sheet
Insmed has $1.68B in cash and marketable securities with $745.08M in debt, giving a net cash position of $934.91M billion.
Cash & Marketable Securities$1.68B
Total Debt$745.08M
Net Cash$934.91M
Net Cash Per Share$4.38
Tangible Book Value Per Share$0.55
Margins
Gross margin is 69.97%, with operating margin of -241.47%, and net profit margin of -251.24%.
Gross Margin69.97%
Operating Margin-241.47%
Pretax Margin-250.22%
Net Profit Margin-251.24%
EBITDA Margin-225.12%
EBIT Margin-228.15%
Analyst Forecast
The average price target for Insmed is $199.81, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$199.81
Price Target Upside-0.90% Downside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast30.34%
EPS Growth Forecast-11.26%